Genentech Executive Vice President Richard Scheller discusses some of the thought-provoking ethical issues that arise in the drug development process. To illuminate the issue, Scheller describes the painful challenges of the clinical trial placebo process, often required by the Food and Drug Administration. He also articulates some of the ethical implications related to drug costs and insurance reimbursements.
Related

Ravi Mhatre,
Lightspeed Venture Partners
The Language of Technology [Entire Talk]
Successful technology investing requires both cutting-edge ideas and patient, determined strategy.
Video
45 minutes
Ravi Mhatre,
Lightspeed Venture Partners
The Language of Technology [Entire Talk]
Successful technology investing requires both cutting-edge ideas and patient, determined strategy.

Tom Byers,
Stanford University
Entrepreneurship and Ethics
A five-episode podcast miniseries focused on infusing ethics into entrepreneurship education.
Article
3 minutes

Sylvia Acevedo,
Path to the Stars: My Journey from Girl Scout to Rocket Scientist
Perseverance Creates Opportunity [Entire Talk]
Self-confidence unlocks a wealth of opportunities.
Video
48 minutes
Sylvia Acevedo,
Path to the Stars: My Journey from Girl Scout to Rocket Scientist
Perseverance Creates Opportunity [Entire Talk]
Self-confidence unlocks a wealth of opportunities.